Eqva ASA
OSE:EQVA

Watchlist Manager

Eqva ASA

OSE:EQVA

Watchlist

Dividends

Discount Rate

Price: 4.91 NOK 3.15%

Market Cap: 351.6m NOK

Have any thoughts about
Eqva ASA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 4.91 NOK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

EQVA Alert

Eqva ASA

4.91

+0.15 (+3.15%)

52 Week Range	2.7 6.86
Price Target

We'll email you a reminder when the closing price reaches NOK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Eqva ASA

What unique competitive advantages
does Eqva ASA hold over its rivals?

What risks and challenges
does Eqva ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Eqva ASA.

What unique competitive advantages
does Eqva ASA hold over its rivals?

What risks and challenges
does Eqva ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Eqva ASA.

Provide P/S
for Eqva ASA.

Provide P/E
for Eqva ASA.

Provide P/OCF
for Eqva ASA.

Provide P/FCFE
for Eqva ASA.

Provide P/B
for Eqva ASA.

Provide EV/S
for Eqva ASA.

Provide EV/GP
for Eqva ASA.

Provide EV/EBITDA
for Eqva ASA.

Provide EV/EBIT
for Eqva ASA.

Provide EV/OCF
for Eqva ASA.

Provide EV/FCFF
for Eqva ASA.

Provide EV/IC
for Eqva ASA.

Compare the intrinsic valuations
of Eqva ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Eqva ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Eqva ASA compared to its peers.

Compare the P/E ratios
of Eqva ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Eqva ASA with its peers.

Analyze the financial leverage
of Eqva ASA compared to its main competitors.

Show all profitability ratios
for Eqva ASA.

Provide ROE
for Eqva ASA.

Provide ROA
for Eqva ASA.

Provide ROIC
for Eqva ASA.

Provide ROCE
for Eqva ASA.

Provide Gross Margin
for Eqva ASA.

Provide Operating Margin
for Eqva ASA.

Provide Net Margin
for Eqva ASA.

Provide FCF Margin
for Eqva ASA.

Show all solvency ratios
for Eqva ASA.

Provide D/E Ratio
for Eqva ASA.

Provide D/A Ratio
for Eqva ASA.

Provide Interest Coverage Ratio
for Eqva ASA.

Provide Altman Z-Score Ratio
for Eqva ASA.

Provide Quick Ratio
for Eqva ASA.

Provide Current Ratio
for Eqva ASA.

Provide Cash Ratio
for Eqva ASA.

What is the historical Revenue growth
over the last 5 years for Eqva ASA?

What is the historical Net Income growth
over the last 5 years for Eqva ASA?

What is the current Free Cash Flow
of Eqva ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Eqva ASA.

EQVA

Balance Sheet

Other Current Liabilities

Eqva ASA
Other Current Liabilities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Eqva ASA
Other Current Liabilities Peer Comparison

Comparables:

HPUR

NKR

PHLY

HAV

ENDUR

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company		Other Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
E	Eqva ASA OSE:EQVA	Other Current Liabilities kr89.7m	CAGR 3-Years -52%	CAGR 5-Years -41%	CAGR 10-Years -7%
H	Hexagon Purus ASA OSE:HPUR	Other Current Liabilities kr436.3m	CAGR 3-Years 95%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Nekkar Asa OSE:NKR	Other Current Liabilities kr124.7m	CAGR 3-Years -6%	CAGR 5-Years -39%	CAGR 10-Years -20%
	Philly Shipyard ASA OSE:PHLY	Other Current Liabilities $282m	CAGR 3-Years -8%	CAGR 5-Years 390%	CAGR 10-Years 32%
H	Hav Group ASA OSE:HAV	Other Current Liabilities kr228.4m	CAGR 3-Years -8%	CAGR 5-Years N/A	CAGR 10-Years N/A
E	Endur ASA OSE:ENDUR	Other Current Liabilities kr46.3m	CAGR 3-Years 38%	CAGR 5-Years 4%	CAGR 10-Years -19%

What is Eqva ASA's Other Current Liabilities?

Other Current Liabilities
89.7m NOK

Based on the financial report for Jun 30, 2024, Eqva ASA's Other Current Liabilities amounts to 89.7m NOK.

What is Eqva ASA's Other Current Liabilities growth rate?

Other Current Liabilities CAGR 10Y
-7%

Over the last year, the Other Current Liabilities growth was -26%. The average annual Other Current Liabilities growth rates for Eqva ASA have been -52% over the past three years , -41% over the past five years , and -7% over the past ten years .

Eqva ASA
OSE:EQVA

Eqva ASA
Other Current Liabilities

Eqva ASA
Other Current Liabilities Peer Comparison

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

See Also

What is Eqva ASA's Other Current Liabilities?

Other Current Liabilities
89.7m NOK

What is Eqva ASA's Other Current Liabilities growth rate?

Other Current Liabilities CAGR 10Y
-7%

Company

Help

Tools

Stocks

Eqva ASA OSE:EQVA

Eqva ASA Other Current Liabilities

Eqva ASA Other Current Liabilities Peer Comparison

Competitive Other Current Liabilities Analysis Latest Figures & CAGR of Competitors

See Also

What is Eqva ASA's Other Current Liabilities? Other Current Liabilities 89.7m NOK

What is Eqva ASA's Other Current Liabilities growth rate? Other Current Liabilities CAGR 10Y -7%

Company

Help

Tools

Stocks

Eqva ASA
OSE:EQVA

Eqva ASA
Other Current Liabilities

Eqva ASA
Other Current Liabilities Peer Comparison

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

What is Eqva ASA's Other Current Liabilities?

Other Current Liabilities
89.7m NOK

What is Eqva ASA's Other Current Liabilities growth rate?

Other Current Liabilities CAGR 10Y
-7%